SCHEMBL21751453

SCHEMBL21751453

O=c1c(Cc2ccco2)nc2c(Cc3ccccc3)[nH]c(-c3cc(O)cc(Cl)c3)cn1-2

nearest known ligand 0.33

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ADORA2A P29274 6/20 0.33
▸ ADORA2B P29275 6/20 0.33
▸ PSD A5PKW4 3/20 0.33
▸ ARF6 P62330 2/20 0.33
▸ ALDH1A1 P00352 4/20 0.32
▸ POLB P06746 3/20 0.32
▸ PKM P14618 3/20 0.32
▸ MEN1 O00255 2/20 0.32
▸ KMT2A Q03164 2/20 0.32
▸ TSHR P16473 3/20 0.32
▸ USP2 O75604 2/20 0.32
▸ MAPT P10636 2/20 0.32
▸ CASP1 P29466 2/20 0.32
▸ BLM P54132 2/20 0.32
▸ CASP7 P55210 2/20 0.32
▸ NPSR1 Q6W5P4 2/20 0.32
▸ HSD17B10 Q99714 2/20 0.32
▸ LMNA P02545 2/20 0.32
▸ TP53 P04637 1/20 0.32
▸ GAA P10253 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21751357 0.90 ALDH1A1 (0.34) ADORA2AADORA2BALDH1A1POLBTSHR
SCHEMBL25760359 0.90 ADORA2B (0.37) ADORA2AADORA2BARF6ALDH1A1POLB
SCHEMBL30110483 0.89 ALDH1A1 (0.38) ADORA2AADORA2BALDH1A1POLBMEN1
SCHEMBL19810232 0.89 ALDH1A1 (0.38) ADORA2AADORA2BALDH1A1POLBMEN1
SCHEMBL28888591 0.88 PSD (0.38) ADORA2AADORA2BPSDALDH1A1POLB
SCHEMBL5560844 0.88 ALDH1A1 (0.37) ADORA2AADORA2BALDH1A1KMT2ATSHR
SCHEMBL21751352 0.87 BRAF (0.34) ADORA2AADORA2BARF6ALDH1A1POLB
SCHEMBL2670126 0.86 ALDH1A1 (0.39) ADORA2AADORA2BALDH1A1POLBPKM
SCHEMBL28396528 0.85 ADORA2B (0.39) ADORA2AADORA2BALDH1A1POLBTSHR
SCHEMBL21751428 0.85 ADORA2A (0.32) ADORA2AADORA2BPSDALDH1A1POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3981839-B1 COELENTERAZINE ANALOGS FOR USE IN LUCIFERASE-BASED ASSAYS PROMEGA CORP (US) 2025-08-20 — — EP disclosed
US-20240059697-A1 COELENTERAZINE ANALOGUES PROMEGA CORPORATION 2024-02-22 — — US disclosed
US-11691976-B2 Coelenterazine analogues PROMEGA CORPORATION (US) 2023-07-04 — — US disclosed
US-11691976-B2 Coelenterazine analogues PROMEGA CORPORATION (US) 2023-07-04 — — US disclosed
US-11691976-B2 Coelenterazine analogues PROMEGA CORPORATION (US) 2023-07-04 — — US disclosed
EP-3841173-A1 COELENTERAZINE ANALOGUES Promega Corporation (US) 2021-06-30 — — EP disclosed
WO-2020041579-A1 COELENTERAZINE ANALOGUES PROMEGA CORPORATION (US) 2020-02-27 — — WO disclosed
US-20200062766-A1 COELENTERAZINE ANALOGUES PROMEGA CORPORATION 2020-02-27 — — US disclosed
US-20200062766-A1 COELENTERAZINE ANALOGUES PROMEGA CORPORATION 2020-02-27 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200062766-A1 COELENTERAZINE ANALOGUES GLB1, SI, TCF7L2 ADORA2A 1970/4885ADORA2B 3105/4885PSD 4369/4885
US-11691976-B2 Coelenterazine analogues GLB1, SI, TCF7L2 ADORA2A 1970/4885ADORA2B 3105/4885PSD 4369/4885
US-20240059697-A1 COELENTERAZINE ANALOGUES GLB1, SI, TCF7L2 ADORA2A 1970/4885ADORA2B 3105/4885PSD 4369/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback